Dr Reddys (Germany) Investor Sentiment

RDDA Stock  EUR 11.50  0.20  1.71%   
Roughly 62% of Dr Reddys' investor base is looking to short. The analysis of current outlook of investing in Dr Reddys Laboratories suggests that many traders are alarmed regarding Dr Reddys' prospects. The current market sentiment, together with Dr Reddys' historical and current headlines, can help investors time the market. In addition, many technical investors use Dr Reddys Laboratories stock news signals to limit their universe of possible portfolio assets.
Dr Reddys stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of RDDA daily returns and investor perception about the current price of Dr Reddys Laboratories as well as its diversification or hedging effects on your existing portfolios.
  
a day ago at news.google.com         
Dr Reddys shares in focus after recall of mislabelled Levetiracetam injection in US - The Economic T...
Google News at Macroaxis
2 days ago at news.google.com         
Vestcor Inc Grows Position in Dr. Reddys Laboratories Limited - MarketBeat
Google News at Macroaxis
3 days ago at news.google.com         
Dr. Reddys Laboratories Faces Bearish Trends Amid Broader Market Gains - MarketsMojo
Google News at Macroaxis
few days ago at news.google.com         
Dr. Reddys Laboratories Reaches New 52-Week Low - Heres What Happened - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
West Family Investments Inc. Boosts Stake in Dr. Reddys Laboratories Limited - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
QRG Capital Management Inc. Has 715,000 Position in Dr. Reddys Laboratories Limited - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
US Bancorp DE Has 3.61 Million Position in Dr. Reddys Laboratories Limited - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Senores Pharmaceuticals Shares Rises 7, acquires 14 ANDAs from Dr. Reddys - BusinessLine
Google News at Macroaxis
over a week ago at news.google.com         
Dr Reddys Laboratories Hits 52-Week Low Amid Broader Pharmaceutical Sector Trends - MarketsMojo
Google News at Macroaxis
over two weeks ago at news.google.com         
Is Dr. Reddys Laboratories Limited the Best Weight Loss Drug Stock to Buy According to Analysts - In...
Google News at Macroaxis
over two weeks ago at news.google.com         
These 8 healthcare stocks hit 52-week low, fell up to 26 percent in a month - The Economic Times
Google News at Macroaxis
over two weeks ago at news.google.com         
Dr Reddys Laboratories Faces Market Challenges Amid Significant Stock Decline - MarketsMojo
Google News at Macroaxis
over three weeks ago at news.google.com         
Blue Trust Inc. Has 522,000 Stock Holdings in Dr. Reddys Laboratories Limited - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Dr. Reddys Allots Equity Shares Under Employee Stock Options - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Dr Reddys Share Price Live Updates Dr. Reddys Laboratories showcases stability with low beta - The E...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Dr Reddys that are available to investors today. That information is available publicly through RDDA media outlets and privately through word of mouth or via RDDA internal channels. However, regardless of the origin, that massive amount of RDDA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dr Reddys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dr Reddys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dr Reddys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dr Reddys alpha.

Dr Reddys Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for RDDA Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance